Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
01-2012 | 12-2011 | 10-2011 | 09-2011 | 07-2011 | |
Sales | 9,157 | 38 | 7,320 | 45 | 6,421 |
Cost of Goods | 5,796 | 429 | 5,309 | 217 | 5,004 |
Gross Profit | 3,361 | -391 | 2,011 | -172 | 1,417 |
Operating Expenses | 2,549 | 3,938 | 1,984 | 3,602 | 1,642 |
Operating Income | 1,608 | -3,900 | 336 | -3,557 | -221 |
Interest Expense | 83 | 20 | 84 | 9 | 86 |
Other Income | -122 | 805 | 46 | 826 | -3 |
Pre-tax Income | 1,403 | -3,115 | 298 | -2,740 | -310 |
Income Tax | 673 | N/A | 152 | N/A | -143 |
Net Income Continuous | 730 | -3,115 | 146 | -2,740 | -167 |
Net Income | $730 | $-3,115 | $146 | $-2,740 | $-167 |
EPS Basic Total Ops | 0.18 | -10.58 | 0.04 | -10.58 | -0.04 |
EPS Basic Continuous Ops | 0.19 | -12.16 | 0.04 | -10.69 | -0.04 |
EPS Diluted Total Ops | 0.18 | -10.58 | 0.04 | -10.58 | -0.04 |
EPS Diluted Continuous Ops | 0.19 | -12.16 | 0.04 | -10.69 | -0.04 |
EBITDA(a) | $1,759 | $-3,753 | $450 | $-3,382 | $-43 |